Ke Qian

419 total citations
17 papers, 319 citations indexed

About

Ke Qian is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ke Qian has authored 17 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Ke Qian's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and MicroRNA in disease regulation (2 papers). Ke Qian is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and MicroRNA in disease regulation (2 papers). Ke Qian collaborates with scholars based in China. Ke Qian's co-authors include Zonglin Chen, Xundi Xu, Fang Yu, Gao Liu, Yibo Hu, Zhonghua Tang, Enxiang Zhou, Zhonghua Tang, Xia Wu and Xianyu Chen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Archives of Biochemistry and Biophysics.

In The Last Decade

Ke Qian

17 papers receiving 314 citations

Peers

Ke Qian

ONCOL

IMMUN

EPIDE

Rongjie Zhao China

Wei Wen China

Zhaojie Lv China

Zefeng Xuan China

Katy Billot France

Feng Ye China

Chunjuan Zhao China

Mujian Teng China

Xu Lu China

Rongjie Zhao China

Ke Qian

162 ×0.9

102 ×0.6

60 ×0.7

ONCOL

22 ×0.4

IMMUN

18 ×0.7

EPIDE

Citations per year, relative to Ke Qian Ke Qian (= 1×) peers Rongjie Zhao

Countries citing papers authored by Ke Qian

Since Specialization

Citations

This map shows the geographic impact of Ke Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Qian more than expected).

Fields of papers citing papers by Ke Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Qian. The network helps show where Ke Qian may publish in the future.

Co-authorship network of co-authors of Ke Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Qian. A scholar is included among the top collaborators of Ke Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Qian. Ke Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Qian, Ke, et al.. (2024). TFE3–SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells. Journal of Biological Chemistry. 300(5). 107270–107270. 4 indexed citations

Ouyang, Dengjie, Qitong Chen, Liyun Zeng, et al.. (2024). Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer. BMC Cancer. 24(1). 50–50. 1 indexed citations

Zhang, Chengkai, Wenjianlong Zhou, Dainan Zhang, et al.. (2023). Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis. Open Medicine. 18(1). 20220574–20220574. 2 indexed citations

Cao, Zhenyu, Liyun Zeng, Zicheng Wang, Yi Zhou, & Ke Qian. (2023). Role of miR-5010-3p in predicting the prognosis of hepatocellular carcinoma.. PubMed. 48(9). 1281–1295. 1 indexed citations

Qian, Ke, et al.. (2022). Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease. Frontiers in Cardiovascular Medicine. 9. 829347–829347. 6 indexed citations

Chen, Yan, et al.. (2022). Construction and Validation of a Newly Prognostic Signature for CRISPR-Cas9-Based Cancer Dependency Map Genes in Breast Cancer. Journal of Oncology. 2022. 1–16. 3 indexed citations

Qian, Ke, et al.. (2019). Clinical Features, Magnetic Resonance Imaging, and Treatment Experience of 20 Patients with Lymphocytic Hypophysitis in a Single Center. World Neurosurgery. 127. e22–e29. 15 indexed citations

Cao, Xiaocheng, Fang Yu, Guoxing Liu, et al.. (2018). Transient receptor potential vanilloid-type 2 targeting on stemness in liver cancer. Biomedicine & Pharmacotherapy. 105. 697–706. 34 indexed citations

Ouyang, Dengjie, Juan Su, Peng Huang, et al.. (2018). Identification of lncRNAs via microarray analysis for predicting HER2-negative breast cancer response to neoadjuvant chemotherapy.. PubMed. 11(5). 2621–2628. 14 indexed citations

10.

Liu, Gao, Fang Yu, Zhenyu Cao, et al.. (2017). Clinicopathological and Prognostic Value of CD24 Expression in Breast Cancer: A Meta-Analysis. The International Journal of Biological Markers. 32(2). 182–189. 5 indexed citations

11.

Yao, Hongliang, Sanlin Lei, Li Xiong, et al.. (2017). The miR-124-p63 feedback loop modulates colorectal cancer growth. Oncotarget. 8(17). 29101–29115. 20 indexed citations

12.

Wang, Xiaowei, Quan Wang, Jinhui Tian, et al.. (2017). Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis. Future Oncology. 13(11). 1021–1034. 35 indexed citations

13.

Qian, Ke, Gao Liu, Zhonghua Tang, et al.. (2016). The long non-coding RNA NEAT1 interacted with miR-101 modulates breast cancer growth by targeting EZH2. Archives of Biochemistry and Biophysics. 615. 1–9. 98 indexed citations

14.

Song, Yunjia, Yuan Lv, Lanqing Cui, et al.. (2016). cfr -mediated linezolid-resistant clinical isolates of methicillin-resistant coagulase-negative staphylococci from China. Journal of Global Antimicrobial Resistance. 8. 1–5. 14 indexed citations

15.

Xie, Chengzhi, Zhenhui Lu, Guoxing Liu, et al.. (2015). Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma. International Journal of Molecular Medicine. 36(3). 653–660. 9 indexed citations

16.

Chen, Zonglin, Xianyu Chen, Enxiang Zhou, et al.. (2014). Intratumoral CD8+ Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer. PLoS ONE. 9(4). e95475–e95475. 53 indexed citations

17.

Yu, Shuqing, et al.. (2011). Clinical characteristics and therapeutic strategies of atypical meningioma.. PubMed. 124(7). 1094–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact